Abstract
CD19 chimeric antigen receptor (CAR) T cell therapy has shown impressive results in treating acute lymphoblastic leukemia (B-ALL), chronic lymphoblastic leukemia (B-CLL), and B-cell non-Hodgkin lymphoma (B-NHL) over the past few years. Meanwhile, the cytokine release syndrome (CRS), which could be moderate or even life-threatening, has emerged as the most significant adverse effect in the clinical course of this novel targeting immunotherapy. In this systematic review, we analyzed the incidence of severe CRS in 19 clinical trials selected from studies published between 2010 and 2017. The pooled severe CRS proportion was 29.3% (95% confidence interval [CI] 12.3-49.1%) in B-ALL, 38.8% (95%CI 12.9-67.6%) in B-CLL, and 19.8% (95%CI 4.2-40.8%) in B-NHL. In the univariate meta regression analysis, the proliferation of CD19-CAR-T cell in vivo was correlated with the severe CRS. Specifically, total infusion cell dose contributed to the severe CRS occurring in B-ALL patients but not in B-CLL or B-NHL patients. Tumor burden was strongly associated with the severity of CRS in B-ALL. Besides, post-HSCT CD19 CAR-T cell infusion represented lower severe CRS incidence. Further investigations into the risk factors of CRS in B-CLL and B-NHL are...Continue Reading
References
May 5, 2011·The Journal of Clinical Investigation·Barbara SavoldoGianpietro Dotti
Aug 19, 2011·Blood·Renier J BrentjensMichel Sadelain
Dec 14, 2011·Blood·James N KochenderferSteven A Rosenberg
Sep 14, 2013·Blood·Conrad Russell Y CruzGianpietro Dotti
Sep 24, 2013·Blood·James N KochenderferSteven A Rosenberg
Feb 21, 2014·Science Translational Medicine·Marco L DavilaRenier Brentjens
Aug 27, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James N KochenderferSteven A Rosenberg
Oct 16, 2014·The New England Journal of Medicine·Shannon L MaudeStephan A Grupp
Oct 17, 2014·Lancet·Daniel W LeeCrystal L Mackall
Dec 19, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Keisuke WatanabeMakoto Murata
Sep 4, 2015·Science Translational Medicine·David L PorterCarl H June
Oct 10, 2015·Oncoimmunology·Hanren DaiWeidong Han
Jan 10, 2016·Biochimica Et Biophysica Acta·M NorelliA Bondanza
Jan 27, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer N BrudnoJames N Kochenderfer
Feb 18, 2016·Immunity·Omkar U KawalekarCarl H June
Apr 15, 2016·Cancer Discovery·David T TeacheyStephan A Grupp
Apr 26, 2016·The Journal of Clinical Investigation·Cameron J TurtleDavid G Maloney
Apr 28, 2016·Blood·Xiuli WangStephen J Forman
May 22, 2016·Blood·Jennifer N Brudno, James N Kochenderfer
Aug 3, 2016·The Journal of Clinical Investigation·Partow KebriaeiLaurence J N Cooper
Sep 9, 2016·Science Translational Medicine·Cameron J TurtleDavid G Maloney
Dec 4, 2016·Hematology·Noelle V Frey, David L Porter
Jan 1, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yongxian HuHe Huang
Jan 28, 2017·Immunotherapy·Faiz AnwerIrbaz Bin Riaz
Jan 28, 2017·Molecular Therapy : the Journal of the American Society of Gene Therapy·Frederick L LockeWilliam Y Go
Mar 16, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James N KochenderferSteven A Rosenberg
Sep 20, 2017·Blood·Kevin A HayCameron J Turtle
Citations
Jun 13, 2019·Hematological Oncology·David Sermer, Renier Brentjens
Oct 24, 2019·Recent Patents on Anti-cancer Drug Discovery·Romeo G Mihăilă
Jan 30, 2019·Annals of Hematology·Tiantian MaHuasheng Liu
Jan 23, 2019·Current Oncology Reports·Ibrahim AldossAnthony S Stein
Jan 29, 2019·Frontiers in Immunology·Robert Sackstein
Apr 10, 2019·The AAPS Journal·Jonathan P MochelSaad S Kenderian
Jul 25, 2020·Intensive Care Medicine·Elie AzoulaySandrine Valade
Jan 24, 2021·Journal of Biomedical Science·Tomasz Klaus, Sameer Deshmukh
Dec 29, 2020·Journal for Immunotherapy of Cancer·Sattva S NeelapuMichael R Bishop
Nov 21, 2020·International Journal of Molecular Sciences·Wen-Ying LinYi-Yen Lee
Mar 2, 2021·Frontiers in Immunology·Xinjie XuYuhua Li
Apr 16, 2020·Acta Biomaterialia·Waqas NawazZhiwei Wu
Oct 26, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M-L SchubertP Dreger
Mar 12, 2021·The Journal of Immunology : Official Journal of the American Association of Immunologists·Victor E Tedesco, Chandra Mohan
Apr 25, 2021·The Lancet. Haematology·Élie AzoulayUNKNOWN Nine-I investigators
Apr 29, 2021·Drug and Therapeutics Bulletin·Kayleigh Kew
Sep 14, 2021·The Cochrane Database of Systematic Reviews·Moritz ErnstMarius Goldkuhle
Oct 7, 2021·Scientific Reports·Ditte E JæhgerThomas L Andresen
Nov 3, 2021·Frontiers of Medicine·Lei FanJianyong Li
Oct 14, 2021·Blood Advances·Vanessa E KennedySandy W Wong
Sep 16, 2021·Blood·Daniel A LichtensteinNirali N Shah